Bv369 Trust files Form 144 planned sale of NTRA worth $17.2MBv369 Trust 提交 Form 144，计划减持 NATERA, INC. (NTRA) $17.2M
Planned Large Proposed Sale Notice
At 16:12:54 UTC on June 1, 2026, the U.S. Securities and Exchange Commission (SEC) accepted a Form 144 filing from BV369 TRUST, an affiliate of Natera, Inc. (ticker: NTRA). The full filing is available at https://www.sec.gov/Archives/edgar/data/1604821/000195004726005354/primary_doc.xml. The filing discloses the affiliate intends to sell 78,000 shares of NTRA common stock, with an aggregate market value of approximately $17.2 million, for a planned sale date of June 1, 2026. Form 144 is a mandatory U.S. securities law notice of proposed restricted securities sales, and only communicates an intent to sell, not proof of an executed transaction.
Contextual Background
This proposed sale is not an isolated event: since May 2026, Natera has seen multiple Form 4 insider sale transactions, including two executives selling a combined ~3,090 shares on May 28, and co-founder Sheena Jonathan selling a total of ~3,388 shares across seven separate trades on May 15. Additionally, as of December 31, 2025, 96.1% of Natera’s float was held by 802 institutional investors, with a total portfolio value of $30.2 billion; 173 new institutional positions were opened, 450 were increased, and 245 were reduced in that quarter. Analyst ratings have remained consistent since February 2026, with 4 strong buy, 13 buy, and 2 hold ratings, with no sell or strong sell ratings. The company also announced positive clinical trial partnerships and Panorama test upgrades in late May and early June 2026.
Limitations of This Signal
1. This filing only communicates a proposed sale; BV369 TRUST may adjust or cancel the sale plan, and no shares have actually been sold as of the filing date;
2. The sale may reflect only the affiliate’s short-term liquidity needs or portfolio diversification, and does not directly signal a negative view of the company’s long-term fundamentals;
3. This disclosure does not constitute any investment advice, and cannot be used to directly predict future stock price movements.
拟议大额出售通知
2026年6月1日16:12:54，美国证券交易委员会（SEC）接受了NATERA, INC.（股票代码：NTRA）关联方BV369 TRUST提交的Form 144文件，完整文件可通过指定EDGAR链接查询。该文件披露，该关联方拟出售78,000股NTRA普通股，总市值约1720万美元，计划出售日期为2026年6月1日。根据美国证券法，Form 144是限制性证券拟出售的强制通知文件，仅披露出售意向，并非已完成交易的证明。
关联背景参考
此次拟议出售并非孤立事件：2026年5月以来，NTRA已有多笔内部人士Form 4出售交易，包括5月28日两位高管合计出售约3090股，联合创始人Sheena Jonathan于5月15日分7笔交易合计出售约3388股。同时，截至2025年12月31日，NTRA流通股的96.1%由802家机构投资者持有，总持仓市值达302亿美元；当季度有173家新增持仓、450家机构加仓、245家机构减仓。分析师评级自2026年2月起连续三个月维持4份强力买入、13份买入、2份持有，无卖出或强力卖出评级。近期公司还公布了与Diakonos的临床试验合作及Panorama检测升级的利好消息。
该信号的局限性
1. 该文件仅为拟议出售通知，BV369 TRUST可能调整或取消出售计划，截至文件提交日尚未完成任何股份减持；
2. 此次出售可能仅为关联方的短期流动性安排或资产多元化操作，不直接反映对公司长期基本面的判断；
3. 本披露不构成任何投资建议，也无法直接推断公司股价未来走势。
This analysis was generated by InvestLog AI based on SEC filings, Form 4 insider transactions, Form 144 planned-sale notices, 13F institutional holdings, analyst ratings, and market data. It is for informational purposes only and does not constitute investment advice.这篇研究由 InvestLog AI 基于 SEC 披露、Form 4 内部人交易、Form 144 计划减持、13F 机构持仓、分析师评级和市场数据生成。内容仅供参考，不构成投资建议。